Invention Grant
- Patent Title: Treatment of prostate cancer using hedgehog pathway inhibitors
-
Application No.: US15966844Application Date: 2018-04-30
-
Publication No.: US10363252B2Publication Date: 2019-07-30
- Inventor: Nicholas J. Virca , Francis E. O'Donnell, Jr.
- Applicant: HEDGEPATH PHARMACEUTICALS, INC.
- Applicant Address: US FL Tampa
- Assignee: HEDGEPATH PHARMACEUTICALS, INC.
- Current Assignee: HEDGEPATH PHARMACEUTICALS, INC.
- Current Assignee Address: US FL Tampa
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/00 ; A61K31/497 ; A61K31/415 ; A61K45/06 ; A61K31/519 ; A61K31/58 ; A61K33/24 ; A61K9/00 ; G01N33/574 ; A61K9/48
Abstract:
The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.
Public/Granted literature
Information query
IPC分类:
